Effective Use of ALK Inhibitors in EML4::ALK Positive Lymphatic
Malformations
Beth Apsel Winger1,2, Christopher F.
Dowd3, Kristin A. Shimano2, W.
Patrick Devine4, Erin Mathes5, Ilona
Frieden5, Carrie Schaefer6, Alok
Kothari7
1Department of Clinical Pharmacy, UCSF, San Francisco
CA
2Division of Pediatric Hematology, UCSF, San Francisco
CA
3Division of Interventional Neuroradiology, UCSF, San
Francisco CA
4Department of Anatomic Pathology, UCSF, San Francisco
CA
5Department of Dermatology, UCSF, San Francisco CA
6Department of Radiology, Phoenix Children’s Hospital,
Phoenix, AZ
7Division of Pediatric Hematology/Oncology, Phoenix
Children’s Hospital, Phoenix, AZ